| 1 |
Extended risk of mortality in children with inborn errors of metabolism: A longitudinal cohort study.
62
|
Auger N...Arbour L
|
36084730 |
2022 |
| 2 |
Update on imaging in chronic kidney disease-mineral and bone disorder: promising role of functional imaging.
62
|
Usmani S...van den Wyngaert T
|
34524489 |
2022 |
| 3 |
[Mineral dysmetabolism in corneal diseases].
62
|
Pateyuk LS...Kobzeva AV
|
36287163 |
2022 |
| 4 |
Basal ganglia calcification in hypoparathyroidism and pseudohypoparathyroidism: local and systemic metabolic mechanisms.
62
|
Zavatta G...Clarke BL
|
32661948 |
2021 |
| 5 |
Genetic variants of mineral metabolism in health and disease.
62
|
Robinson-Cohen C
|
32427690 |
2020 |
| 6 |
Correlation Between Parathyroid Hormone Levels with Urinary Magnesium Excretion in Patients with Non-Dialysis Dependent Chronic Kidney Disease.
62
|
Carneiro Dias RS...Bernardo-Filho M
|
33239901 |
2020 |
| 7 |
Effect of spironolactone on the progression of coronary calcification in peritoneal dialysis patients: a pilot study.
62
|
Gueiros APS...Carvalho AB
|
31419271 |
2019 |
| 8 |
[ASSOCIATION OF FIBROBLAST GROWTH FACTOR 23 WITH MARKERS OF INFLAMMATION AND FIBROSIS IN DIABETIC NEPHROPATHY].
62
|
Topchii I...Shcherban T
|
31560661 |
2019 |
| 9 |
Understanding nationwide readmissions after thyroid surgery.
62
|
Rios-Diaz AJ...Willis AI
|
30545657 |
2019 |
| 10 |
Pseudohypoparathyroidism.
62
|
Cianferotti L...Brandi ML
|
29125274 |
2018 |
| 11 |
Associations of parathyroid hormone levels and mineral parameters with heart rate variability in patients with end-stage renal disease.
62
|
Zhang L...Ren Y
|
28243964 |
2017 |
| 12 |
Neurological, psychological, and cognitive disorders in patients with chronic kidney disease on conservative and replacement therapy.
62
|
Lai S...Lai C
|
27902586 |
2016 |
| 13 |
Persistent disorders of mineral metabolism after one year of kidney transplantation.
62
|
Gomes LK...Nascimento MM
|
27737385 |
2016 |
| 14 |
High-phosphorus diet maximizes and low-dose calcitriol attenuates skeletal muscle changes in long-term uremic rats.
62
|
Acevedo LM...Rivero JL
|
26869708 |
2016 |
| 15 |
Genetic African Ancestry and Markers of Mineral Metabolism in CKD.
62
|
Gutierrez OM...Wolf M
|
26912553 |
2016 |
| 16 |
Associations among time-average mineral values, mortality and cardiovascular events in hemodialysis patients.
62
|
Wu HC...Wang WJ
|
26375759 |
2015 |
| 17 |
Validation of administrative codes for calcium pyrophosphate deposition: a Veterans Administration study.
62
|
Bartels CM...Rosenthal AK
|
26010181 |
2015 |
| 18 |
A Practical Approach to Hypocalcaemia in Children.
62
|
Shaw NJ
|
26138837 |
2015 |
| 19 |
Oral manifestations in a renal osteodystrophy patient - a case report with review of literature.
62
|
J P...Mm V
|
25302278 |
2014 |
| 20 |
[Mineral metabolism in patients on chronic peritoneal dialysis].
62
|
Ceballos O ML...Cano Sch F
|
25079181 |
2014 |
| 21 |
Neurologic disorders of mineral metabolism and parathyroid disease.
62
|
Agrawal L...Emanuele NV
|
24365349 |
2014 |
| 22 |
Disorders of mineral metabolism in the newborn.
62
|
Tuchman S
|
25088267 |
2014 |
| 23 |
Parathyroidectomy and heart rate variability in patients with stage 5 CKD.
62
|
Zhang J...Wang N
|
23660181 |
2013 |
| 24 |
Dialysate calcium concentration and mineral metabolism in long and long-frequent hemodialysis: a systematic review and meta-analysis for a Canadian Society of Nephrology clinical practice guideline.
62
|
Zimmerman DL...Mustafa RA
|
23591289 |
2013 |
| 25 |
Association of calcium, phosphate and parathyroid hormone with renal allograft function: a retrospective cohort study.
62
|
Hiemstra TF...Walsh M
|
23548209 |
2013 |
| 26 |
[Programmed approach to the treatment of secondary hyperparathyroidism in chronic renal disease].
62
|
Samokhvalov NA...Romashchenko PN
|
24000678 |
2013 |
| 27 |
1,25-Dihydroxy vitamin D and coronary microvascular function.
62
|
Capitanio S...Marini C
|
23151909 |
2013 |
| 28 |
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
62
|
EVOLVE Trial Investigators...Parfrey PS
|
23121374 |
2012 |
| 29 |
[Wnt pathway and sclerostin as new targets for assessment and treatment of osteoporosis].
62
|
Alonso G...Munoz-Torres M
|
22613824 |
2012 |
| 30 |
Fibroblast growth factor 23: state of the field and future directions.
62
|
Bhattacharyya N...Collins MT
|
22921867 |
2012 |
| 31 |
Calcium regulation of vascular smooth muscle cell-derived matrix vesicles.
62
|
Kapustin AN...Shanahan CM
|
22902179 |
2012 |
| 32 |
Reduced circulating miR-15b is correlated with phosphate metabolism in patients with end-stage renal disease on maintenance hemodialysis.
62
|
Wang H...Dai Y
|
22512691 |
2012 |
| 33 |
Capillary rarefaction in advanced chronic kidney disease is associated with high phosphorus and bicarbonate levels.
62
|
Thang OH...Nube MJ
|
21414968 |
2011 |
| 34 |
Hepcidin and disordered mineral metabolism in chronic kidney disease.
62
|
Carvalho C...Gutierrez OM
|
21762639 |
2011 |
| 35 |
Impaired regulation of calcium excretion in kidney transplant recipients.
62
|
Smalcelj R...Kusec V
|
21667092 |
2011 |
| 36 |
Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients.
62
|
Noordzij M...NECOSAD Study Group
|
20880929 |
2011 |
| 37 |
The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial.
62
|
Walsh M...Culleton B
|
20041960 |
2010 |
| 38 |
Vascular calcification in chronic kidney disease.
62
|
Covic A...Goldsmith DJ
|
20443781 |
2010 |
| 39 |
Association of calcium-phosphorus product with blood pressure in dialysis.
62
|
Ashkar ZM
|
20167032 |
2010 |
| 40 |
Therapeutic implications of osteoprotegerin.
62
|
Fili S...Schaller B
|
19747396 |
2009 |
| 41 |
[Mineral substances in the bone tissue and blood of patients with osteoporosis].
62
|
Ajdukovic Z...Ignjatovic N
|
20391733 |
2009 |
| 42 |
Bone mineral density and disorders of mineral metabolism in chronic liver disease.
62
|
George J...Shah N
|
19630107 |
2009 |
| 43 |
Fibroblast growth factor 23: uremic toxin or innocent bystander in chronic kidney disease?
62
|
Stubbs JR...Quarles LD
|
19534362 |
2009 |
| 44 |
A practical approach to hypocalcaemia in children.
62
|
Shaw N
|
19494662 |
2009 |
| 45 |
Disorders involving calcium, phosphorus, and magnesium.
62
|
Moe SM
|
18486714 |
2008 |
| 46 |
Therapeutic strategies to slow chronic kidney disease progression.
62
|
Wuhl E...Schaefer F
|
18335252 |
2008 |
| 47 |
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.
62
|
Gutierrez OM...Wolf M
|
18256597 |
2008 |
| 48 |
Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
62
|
Ishimura E...Nishizawa Y
|
18097148 |
2008 |
| 49 |
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
62
|
Lorenzo Sellares V...Torregrosa V
|
19018742 |
2008 |
| 50 |
CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.
62
|
Vega D...Sakhaee K
|
17895323 |
2007 |
Inborn errors of metabolism 